113 related articles for article (PubMed ID: 19883306)
1. Good things come in small packages: low-dose radiation as palliation for indolent non-Hodgkin lymphomas.
Martin NE; Ng AK
Leuk Lymphoma; 2009 Nov; 50(11):1765-72. PubMed ID: 19883306
[TBL] [Abstract][Full Text] [Related]
2. Palliation by low-dose local radiation therapy for indolent non-Hodgkin lymphoma.
Chan EK; Fung S; Gospodarowicz M; Hodgson D; Wells W; Sun A; Pintile M; Tsang RW
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e781-6. PubMed ID: 21167657
[TBL] [Abstract][Full Text] [Related]
3. Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?
Specht L
Curr Treat Options Oncol; 2016 Jan; 17(1):4. PubMed ID: 26739151
[TBL] [Abstract][Full Text] [Related]
4. Low dose palliative radiotherapy in low grade non-Hodgkin's lymphoma.
Sawyer EJ; Timothy AR
Radiother Oncol; 1997 Jan; 42(1):49-51. PubMed ID: 9132826
[TBL] [Abstract][Full Text] [Related]
5. Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomas.
Saleh K; Michot JM; Schernberg A; Lazarovici J; Chahine C; Danu A; Khalife-Saleh N; Rossignol J; Ghez D; Martin V; Mazeron R; Fermé C; Boros A; Ribrag V; Girinsky T
Cancer Med; 2020 Jun; 9(11):3725-3732. PubMed ID: 32249547
[TBL] [Abstract][Full Text] [Related]
6. Value of low-dose 2 x 2 Gy palliative radiotherapy in advanced low-grade non-Hodgkin's lymphoma.
Ng M; Wirth A; Ryan G; MacManus M; Davis S
Australas Radiol; 2006 Jun; 50(3):222-7. PubMed ID: 16732818
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: a phase II study.
Murthy V; Thomas K; Foo K; Cunningham D; Johnson B; Norman A; Horwich A
Clin Lymphoma Myeloma; 2008 Aug; 8(4):241-5. PubMed ID: 18765312
[TBL] [Abstract][Full Text] [Related]
8. Low-grade non-hodgkin lymphomas.
Tsang RW; Gospodarowicz MK
Semin Radiat Oncol; 2007 Jul; 17(3):198-205. PubMed ID: 17591567
[TBL] [Abstract][Full Text] [Related]
9. Rates and durability of response to salvage radiation therapy among patients with refractory or relapsed aggressive non-Hodgkin lymphoma.
Tseng YD; Chen YH; Catalano PJ; Ng A
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):223-31. PubMed ID: 25835625
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunotherapy for indolent B-cell non-Hodgkin lymphoma in relapsed, refractory and transformed disease.
Visser OJ; Perk LR; Zijlstra JM; van Dongen GA; Huijgens PC; van de Loosdrecht AA
BioDrugs; 2006; 20(4):201-7. PubMed ID: 16831019
[TBL] [Abstract][Full Text] [Related]
11. Low-dose involved-field radiation in the treatment of non-hodgkin lymphoma: predictors of response and treatment failure.
Russo AL; Chen YH; Martin NE; Vinjamoori A; Luthy SK; Freedman A; Michaelson EM; Silver B; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):121-7. PubMed ID: 23414765
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy of follicular lymphoma: updated role and new rules.
Yahalom J
Curr Treat Options Oncol; 2014 Jun; 15(2):262-8. PubMed ID: 24700284
[TBL] [Abstract][Full Text] [Related]
13. Recommendations for Radiotherapy Technique and Dose in Extra-nodal Lymphoma.
Hoskin PJ; Díez P; Gallop-Evans E; Syndikus I; Bates A; Bayne M;
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):62-8. PubMed ID: 26456507
[TBL] [Abstract][Full Text] [Related]
14. Response to low-dose involved-field radiotherapy in patients with non-Hodgkin's lymphoma.
Luthy SK; Ng AK; Silver B; Degnan KO; Fisher DC; Freedman AS; Mauch PM
Ann Oncol; 2008 Dec; 19(12):2043-7. PubMed ID: 18647962
[TBL] [Abstract][Full Text] [Related]
15. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial.
Lowry L; Smith P; Qian W; Falk S; Benstead K; Illidge T; Linch D; Robinson M; Jack A; Hoskin P
Radiother Oncol; 2011 Jul; 100(1):86-92. PubMed ID: 21664710
[TBL] [Abstract][Full Text] [Related]
16. [Non-Hodgkin's lymphoma].
Oguchi M; Gomi K; Shikama N
Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Apr; 62(5):206-14. PubMed ID: 12043225
[TBL] [Abstract][Full Text] [Related]
17. Localized low-dose radiotherapy for follicular lymphoma: history, clinical results, mechanisms of action, and future outlooks.
Ganem G; Cartron G; Girinsky T; Haas RL; Cosset JM; Solal-Celigny P
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):975-82. PubMed ID: 20970029
[TBL] [Abstract][Full Text] [Related]
18. Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.
Leonard JP; Gregory SA; Maloney DG; Vose JM; Younes A; Zelenetz AD
Clin Adv Hematol Oncol; 2008 Jun; 6(6):437-45. PubMed ID: 18567989
[TBL] [Abstract][Full Text] [Related]
19. Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients.
Haas RL; Poortmans P; de Jong D; Verheij M; van der Hulst M; de Boer JP; Bartelink H
Eur J Cancer; 2005 Aug; 41(12):1724-30. PubMed ID: 16039113
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunotherapy for the treatment of non-Hodgkin lymphoma: current status and future applications.
Ahmed S; Winter JN; Gordon LI; Evens AM
Leuk Lymphoma; 2010 Jul; 51(7):1163-77. PubMed ID: 20470217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
